Change - Announcement of Appointment::APPOINTMENT OF MR GE SHUMING AS AN EXECUTIVE DIRECTOR AND CHAIRMAN OF THE BOARD

Issuer & Securities

Issuer/ Manager
VERSALINK HOLDINGS LIMITED
Securities
VERSALINK HOLDINGS LIMITED - SG1AC9000003 - 40N
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
20-Jul-2023 00:37:23
Status
New
Announcement Sub Title
APPOINTMENT OF MR GE SHUMING AS AN EXECUTIVE DIRECTOR AND CHAIRMAN OF THE BOARD
Announcement Reference
SG230720OTHRFGSQ
Submitted By (Co./ Ind. Name)
Matthew Law Kian Siong
Designation
Executive Director
Description (Please provide a detailed description of the event in the box below)
Appointment of Mr Ge Shuming as an Executive Director of the Company and Chairman of the Board of Directors of the Company.

This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, ZICO Capital Pte. Ltd. (the "Sponsor"), in accordance with Rule 226(2)(b) of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms. Goh Mei Xian, Director, ZICO Capital Pte. Ltd. at 77 Robinson Road, #06-03 Robinson 77, Singapore 068896, telephone (65) 6636 4201.

Additional Details

Date Of Appointment
19/07/2023
Name Of Person
Ge Shuming
Age
30
Country Of Principal Residence
China
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
The Board of Directors (the "Board") of Versalink Holdings Limited (the "Company") has reviewed and assessed the qualifications, working experience, suitability and expertise of Mr Ge Shuming ("Mr Ge"), the diversity of the Board composition, as well as the recommendation of the Nominating Committee ("NC") of Mr Ge to be appointed as an Executive Director of the Company ("ED") and Chairman of the Board.

The Board is satisfied that Mr Ge has the requisite experience and capabilities to assume the role and responsibilities as an ED and Chairman of the Board, and has approved the appointment of Mr Ge as an ED and Chairman of the Board.
Whether appointment is executive, and if so, the area of responsibility
Executive Director.

Mr Ge will be responsible for the business development of the Company, including but not limited to setting proactive new business goals and objectives and translate such goals and objectives into actions; to lead business decisions to drive the growth of the Company; to identify key personnel to determine competencies required to attain business goals/objectives and to work efficiently and effectively with the management; to lead, manage and develop the team to be effective, unite with the same vision and be motivated to bring that vision to life; to identify potential risks and opportunities within the Company and its environment to protect business interests; and to identify potential sources of investment and organize fundraising efforts.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Director and Chairman of the Board.
Professional qualifications
Bachelor of Pharmaceutical Engineering, Minzu University of China

Master of Business Management, The Hong Kong Polytechnic University
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
Mr Ge is a controlling shareholder of the Company, details as set out below.
Conflict of interests (including any competing business)
Nil
Working experience and occupation(s) during the past 10 years
July 2015 to August 2016
- Vice Director of Central China in Henan Tailong Pharmaceutical Co., Ltd.

September 2016 to May 2018
- Executive General Manager in Shandong Kaiyuan Animal Husbandry Co., Ltd.

June 2018 to September 2020
- Assistant to Chairman in Shandong Kaiyuan Industrial Co., Ltd.

September 2021 to present
- Group Executive Vice President in Shandong Kaiyuan Industrial Co., Ltd.
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
39,208,500 shares of the Company (approximately 29.04%) - Direct Interest
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Nil
Present
Nil
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
Pursuant to Rule 406(3)(a) of the Catalist Rules, the Company will arrange for Mr Ge to attend the relevant training on the roles and responsibilities of a director of a listed issuer in Singapore as prescribed by the Exchange under Practice Note 4D of the Catalist Rules within one year from the date of his appointment to the Board.